Optimization of thymidine kinase-based safety switch for neural cell therapy
Publié dansCells, vol. 11, no. 3, 502
Date de publication2022-01-31
Date de mise en ligne2022-01-31
Résumé
Mots-clés
- SR39
- Penciclovir
- Pluripotent stem cell therapy
- Post-transplantation tumor
- Teratoma
Groupe de recherche
Citation (format ISO)
LOCATELLI, Manon et al. Optimization of thymidine kinase-based safety switch for neural cell therapy. In: Cells, 2022, vol. 11, n° 3, p. 502. doi: 10.3390/cells11030502
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:159490
- DOI : 10.3390/cells11030502
- PMID : 35159311
- PMCID : PMC8834506
URL commercialhttps://www.mdpi.com/2073-4409/11/3/502
ISSN du journal2073-4409